X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Robert Zirkelbach

Robert Zirkelbach Robert Zirkelbach is Executive Vice President of Public Affairs at PhRMA. He joins PhRMA in 2014 after working for seven years representing the health insurance industry. He likes Saturday afternoon BBQs on his deck, traveling, trying new restaurants, and attempting to play golf. He’s an avid, somewhat obsessive, Iowa Hawkeye fan and is lucky to have a wife that loves watching college football on Saturday afternoons.

Recent Posts

New “Let’s Talk About Cost” campaign convenes national dialogue on medicine costs

By Robert Zirkelbach  |    July 12, 2017
Discussions about costs are important. We recognize that many are struggling to access the medicine they need and have important questions about their medicine costs. And we want to help find the...   Read More

Fighting multiple sclerosis: New Together ad illuminates the journey of patient & scientist

By Robert Zirkelbach  |    May 31, 2017
Meet Laurel and Ian. Laurel is a patient living with multiple sclerosis (MS), and Ian is a scientist developing new treatments to help Laurel and the other 2.3 million people with MS live longer,...   Read More

A New World of Medicine: New GOBOLDLY ads showcase groundbreaking scientific advancements

By Robert Zirkelbach  |    May 15, 2017
Today, we released the latest chapter of GOBOLDLY™ advertising titled New World, featuring the extraordinary breakthroughs in science being discovered by biopharmaceutical researchers.   Read More

Why won’t the insurance industry tell the truth about medicine costs?

By Robert Zirkelbach  |    May 10, 2017
Discussions about the cost of medicines are important. We recognize that many patients are struggling to access the medicines they need, and we want to work with policymakers and other health care...   Read More

Fighting disease Together: New ads feature patients and the researchers behind today’s breakthroughs

By Robert Zirkelbach  |    April 19, 2017
Today, we launched our next wave of advertising as part of the GOBOLDLY™ campaign, titled Together, featuring the stories of researchers developing cutting-edge breakthroughs alongside patients...   Read More

This is not a special effect: New video shows the destruction of a rogue cell

By Robert Zirkelbach  |    April 10, 2017
In the latest video of our Cells series, part of the GOBOLDLY™ campaign, we witness the destruction of a rogue cell that causes rheumatoid arthritis (RA), a disease that affects 1.3 million...   Read More

This is not a video game: New TV ad showcases the destruction of a cancer cell by immune system

By Robert Zirkelbach  |    February 5, 2017
Today, as part of our new advertising and public affairs initiative, GOBOLDLY™, we are excited to announce the premier of our newest TV advertisement, Cells, which highlights innovative...   Read More

Are insurers exaggerating medicine costs to justify premium increases? Consumers think so.

By Robert Zirkelbach  |    September 9, 2016
Despite recent headlines, U.S. spending on prescription medicines continues to decline. In fact, new data from Altarum Institute found that spending on prescription medicines grew by just 3.9...   Read More

CSRxP proposals would undermine competitive market, harm patients and innovation

By Robert Zirkelbach  |    April 25, 2016
These so-called market-based proposals are nothing more than a litany of new government regulations and mandates that would undermine the competitive market and empower government bureaucrats and...   Read More

ICYMI: Policy solutions for delivering innovative treatments to patients

By Robert Zirkelbach  |    March 11, 2016
Yesterday, at the PhRMA 2016 Annual Meeting, PhRMA president and CEO Steve Ubl laid out his vision for the organization and released policy solutions for delivering innovative treatments to...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates